Business Description
![Entheon Biomedical Corp Entheon Biomedical Corp logo](https://static.gurufocus.com/logos/0C0000BFNX.png?14)
Entheon Biomedical Corp
NAICS : 325412
SIC : 3741
ISIN : CA5534281038
Share Class Description:
XCNQ:ENBI: Ordinary SharesCompare
Compare
Traded in other countries / regions
ENBI.CanadaENTBF.USA1XU.Germany IPO Date
2018-05-03Description
Entheon Biomedical Corp is a biotechnology research and development company committed to treat addiction and substance use disorders.
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.83 | |||||
Interest Coverage | No Debt | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | -96.46 | |||||
Beneish M-Score | -3.89 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 39.8 | |||||
3-Year EPS without NRI Growth Rate | 40.3 | |||||
3-Year FCF Growth Rate | 41.8 | |||||
3-Year Book Growth Rate | -73.4 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 3.46 | |||||
9-Day RSI | 11.5 | |||||
14-Day RSI | 20.84 | |||||
6-1 Month Momentum % | -13.33 | |||||
12-1 Month Momentum % | -48 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 5.63 | |||||
Quick Ratio | 5.63 | |||||
Cash Ratio | 4.9 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -113.9 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Operating Margin % | -216.15 | |||||
Net Margin % | -215.39 | |||||
FCF Margin % | -204.62 | |||||
ROE % | -71.76 | |||||
ROA % | -59.1 | |||||
ROIC % | -1898.65 | |||||
ROCE % | -72.01 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 3.41 | |||||
PB Ratio | 1.83 | |||||
Price-to-Tangible-Book | 1.88 | |||||
EV-to-EBIT | -1.47 | |||||
EV-to-EBITDA | -1.47 | |||||
EV-to-Revenue | 3.18 | |||||
EV-to-FCF | -1.56 | |||||
Price-to-Net-Current-Asset-Value | 1.88 | |||||
Price-to-Net-Cash | 2.5 | |||||
Earnings Yield (Greenblatt) % | -68.03 | |||||
FCF Yield % | -40.06 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Entheon Biomedical Corp Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil C$) | 0.13 | ||
EPS (TTM) (C$) | -0.044 | ||
Beta | 1.88 | ||
Volatility % | 165.88 | ||
14-Day RSI | 20.84 | ||
14-Day ATR (C$) | 0.010453 | ||
20-Day SMA (C$) | 0.14375 | ||
12-1 Month Momentum % | -48 | ||
52-Week Range (C$) | 0.05 - 0.35 | ||
Shares Outstanding (Mil) | 8.86 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 6 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Entheon Biomedical Corp Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Entheon Biomedical Corp Stock Events
Event | Date | Price(C$) | ||
---|---|---|---|---|
No Event Data |
Entheon Biomedical Corp Frequently Asked Questions
What is Entheon Biomedical Corp(XCNQ:ENBI)'s stock price today?
The current price of XCNQ:ENBI is C$0.08. The 52 week high of XCNQ:ENBI is C$0.35 and 52 week low is C$0.05.
When is next earnings date of Entheon Biomedical Corp(XCNQ:ENBI)?
The next earnings date of Entheon Biomedical Corp(XCNQ:ENBI) is .
Does Entheon Biomedical Corp(XCNQ:ENBI) pay dividends? If so, how much?
Entheon Biomedical Corp(XCNQ:ENBI) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |